Albendazole enantiomeric metabolism and binding to cytosolic proteins in the liver fluke Fasciola hepatica

Veterinary Research Communications

Volumn 33, Issue 2, 2009, Pages 163-173

  Solana, H ^a   Scarcella, S ^a   Virkel, G ^a   Ceriani, C ^a   Rodriguez J ^a   Lanusse, C ^a  

^a UNIVERSIDAD NACIONAL DEL CENTRO DE LA PROVINCIA DE BUENOS AIRES   (Argentina)

Author keywords

Albendazole; Binding to cytosolic proteins; Enantiomeric metabolism; Fasciola hepatica; Triclabendazole resistance

Indexed keywords

ALBENDAZOLE; CELL PROTEIN; CYTOSOL PROTEIN; TRICLABENDAZOLE; UNCLASSIFIED DRUG;

AEROBIC METABOLISM; ARTICLE; BINDING AFFINITY; BINDING COMPETITION; CONTROLLED STUDY; DRUG COMPETITION; DRUG METABOLISM; DRUG OXIDATION; DRUG PROTEIN BINDING; DRUG SENSITIVITY; ENANTIOMER; ENANTIOSELECTIVITY; FASCIOLA HEPATICA; FASCIOLIASIS; LIVER MICROSOME; NONHUMAN;

ALBENDAZOLE; ANIMALS; ANTHELMINTICS; BENZIMIDAZOLES; BINDING, COMPETITIVE; CHROMATOGRAPHY, GEL; CYTOSOL; FASCIOLA HEPATICA; FASCIOLIASIS; HELMINTH PROTEINS; LIVER DISEASES, PARASITIC; MICROSOMES; PROTEIN BINDING; SHEEP; SHEEP DISEASES; STEREOISOMERISM;

FASCIOLA HEPATICA;

EID: 59649107210     PISSN: 01657380     EISSN: None     Source Type: Journal    
DOI: 10.1007/s11259-008-9166-3     Document Type: Article

References (32)

1. Alvarez L, Solana HD, Mottier ML, Virkel GL, Fairweather I, Lanusse CE, 2005. Altered drug influx/efflux and enhanced metabolic activity in triclabendazole-resistant liver flukes. Parasitology 131, 1-10. doi: 10.1017/S0031182005007997
2. Alvarez-Sánchez MA, Mainar-Jaime RC, Pérez-García J and Rojo-Vázquez FA, 2006. Resistance of Fasciola hepatica to triclabendazole and albendazole in sheep in Spain. Vet Rec 159, 424-425
3. Boray JC and De Bono D, (1989). Drug resistance in Fasciola hepatica. In Adv Vet Sci Eds P. M. Outteridge, R. D. Richards. Australia, Artarmon. 166.
4. Brennan GP, Fairweather I, Trudgett A, Hoey E, McCoy, McConville M, Meaney M, Robinson M, McFerran N, Ryan L, Lanusse C, Mottier L, Alvarez L, Solana H, Virkel G and Brophy PM, 2007. Understanding triclabendazole resistance. Exp Mol Pathol 822, 104-109. doi: 10.1016/j.yexmp.2007.01.009
5. Coles G and Stafford K, 2001. Activity of oxyclozanide, nitroxynil, clorsulon and albendazole against adult triclabendazole-resistant. Fasciola hepatica. Vet Rec 148, 723-724.
6. Delatour P, Benoit E, Caude I, Tambute A, 1990. Species differences in the generation of the chiral sulphoxide metabolite of albendazole in sheep and rats. Chirality 2, 156-160 doi: 10.1002/chir.530020306
7. Douch P and Buchanan L, 1979. Some properties of the sulphoxidases and sulphoxide reductases of the cestode Moniezia expansa, the nematode Ascaris suum and mouse liver. Xenobiotica 911, 675-679.
8. Gaasenbeek CP, Moll L, Cornelissen JB, Vellema P and Borgsteede FH, 2001. An experimental study on triclabendazole resistance of Fasciola hepatica in sheep. Vet Parasitol 95, 37-43. doi: 10.1016/ S0304-4017(00)00413-1
9. Galtier P, Alvinerie M and Delatour P, 1986. In vitro sulfoxidation of albendazole by ovine liver microsomes: Assay and frequency of various xenobiotics. Am J Vet Res 47, 447-450.
10. Gottschall D, Theodorides V and Wang R, 1990. The metabolism of benzimidazole anthelmintics. Parasitol Today 6, 118-124. doi: 10.1016/ 0169-4758(90)90228-V
11. Landoni MF, Soraci AL, Delatour P and Lees P, 1997. Enantioselective behaviour of drugs used in domestic animals: A review. J Vet Pharmacol Ther 201, 1-16. doi: 10.1046/j.1365-2885.1997.00045.x
12. Lanusse C, Nare B and Prichard R, 1993. Comparative sulphoxidation of albendazole by sheep and cattle liver microsomes. Xenobiotica 233, 285-95.
13. Lowry O, Rosebrough N, Farr A and Randall R, 1951. Protein measurement with the Folin phenol reagent. J Biol Chem 193, 265-275.
14. Mas-Coma S, 2004. Human Fascioliasis. In Waterborne Zoonoses: Identification, Causes, and Control (eds. Cotruvo, J.A., Dufour, A., Rees, G., Bartram, J., Carr, R., Cliver, D.O., Craun, R., Fayer, R. & Gannon, V.P.J.), World Health Organisation/IWA Publishing, London. 305-322.
15. Mitchell GB, Maris L and Bonniwell MA, 1998. Triclabendazole resistant liver fluke in Scottish sheep. Vet Rec 143, 399.
16. Moll L, Gaasenbeek CP, Vellema P and Borgsteede FH, 2000. Resistance of Fasciola hepatica against triclabendazole in cattle and sheep in The Netherlands. Vet Parasitol 91, 153-158. doi: 10.1016/ S0304-4017(00)00267-3
17. Mottier L, Virkel G, Solana H, Alvarez L, Salles J and Lanusse C, 2004. Triclabendazole biotransformation and comparative diffusion of the parent drug and its oxidized metabolites into Fasciola hepatica. Xenobiotica 34 11/12, 1043-1057. doi: 10.1080/00498250400015285
18. O'Brien DJ, 1998. Fasciolosis: A threat to livestock. Irish Vet J 51, 539-541.
19. Overend DJ and Bowen FL, 1995. Resistance of Fasciola hepatica to triclabendazole. Austral Vet J 72, 275-276. doi: 10.1111/ j.1751-0813.1995.tb03546.x
20. Precious WY and Barrett J, 1989. Xenobiotic metabolism in helminths. Parasitol Today 55, 156-160. doi: 10.1016/0169-4758(89)90080-X
21. Robinson MW, Trudgett A, Hoey EM and Fairweather I, 2002. Triclabendazole-resistant Fasciola hepatica: β-tubulin and response to in vitro treatment with triclabendazole. Parasitology 124: 325-338 doi: 10.1017/S003118200100124X
22. Robinson MW, Lawson J, Trudgett A, Hoey EM and Fairweather I, 2004. The comparative metabolism of triclabendazole sulphoxide by triclabendazole-susceptible and triclabendazole-resistant Fasciola hepatica. Parasitol Res 92: 205-210 doi: 10.1007/s00436-003-1003-6
23. Ryan LA, Hoey E, Trudgett A, Fairweather I, Fuchs M, Robinson MW, Chambers E, Timson DJ, Ryan E, Feltwell T, Ivens A, Bentley G, Johnston D, 2008. Fasciola hepatica expresses multiple α- and β-Tubulin isotypes. Mol Biochem Parasitol, 159, 1: 73-78
24. Solana HD, Rodriguez JA and Lanusse CE, 2001 Comparative metabolism of albendazole and albendazole sulphoxide by different helminth parasites. Parasitol Res 87: 275-280.
25. Solana HD, Sallovitz JM, Lanusse CE and Rodríguez JA, 2002a. Enantioselective binding of albendazole sulphoxide to cytosolic proteins from helminth parasites. Methods Find Exp Clin Pharmacol 241: 7-13 doi: 10.1358/mf.2002.24.1.677121
26. Solana H, Rodríguez J and Lanusse C, 2002b. Triclabendazole interaction with Fasciola hepatica cytosolic protein. Biocell 263: 402.
27. Solana H, Virkel G, Rodriguez J and Lanusse C, 2003. Triclabendazole oxidation by the liver fluke Fasciola hepatica: Identification of the metabolic pathways. Biocell 273: 389
28. Souhaili-El Amri H, Fargetton X, Delatour P and Batt AM, 1987. Sulphoxidation of albendazole by the FAD-containing and cytochrome P-450 dependent mono-oxygenases from pig liver microsomes. Xenobiotica 17: 1159-1168.
29. Testa B, Mayer JM. 1988 Stereoselective drug metabolism and its significance in drug research. Prog Drug Res 32: 249-303. Review
30. Thomas I, Coles GC and Duffus K, 2000. Triclabendazole-resistant Fasciola hepatica in south-west Wales. Vet Rec 146: 200.
31. Virkel G, Lifschitz A, Sallovitz J, Pis A and Lanusse C. 2004. Comparative hepatic and extrahepatic enantioselective sulfoxidation of albendazole and fenbendazole in sheep and cattle. Drug Metab Dispos 32, 5: 536-44 doi: 10.1124/dmd.32.5.536
32. Virkel G, Lifschitz A, Sallovitz J, Pis A and Lanusse C. 2006. Assessment of the main metabolism pathways for the flukicidal compound triclabendazole in sheep. J Vet Pharmacol Ther 29, 3: 213-23 doi: 10.1111/j.1365-2885.2006.00735.x